Dong Liu

Title: The Innovations of Dong Liu

Introduction

Dong Liu is an accomplished inventor based in Basking Ridge, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on benzimidazole derivatives. His research focuses on the modulation of retinoid-related orphan receptor gamma (RORγ), which plays a crucial role in various diseases.

Latest Patents

Dong Liu holds a patent for "Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof." This invention relates to benzimidazole derivatives of formula (I) that act as inhibitors of the RORγ protein. The patent outlines pharmaceutical compositions containing these compounds, their preparation methods, and their therapeutic applications for treating RORγ-mediated diseases or disorders. He has 1 patent to his name.

Career Highlights

Throughout his career, Dong Liu has worked with notable companies in the pharmaceutical industry, including Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His work has contributed to advancements in drug development and therapeutic solutions.

Collaborations

Dong Liu has collaborated with esteemed colleagues in his field, including Yinfa Yan and Minsheng Zhang. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Dong Liu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents for critical health issues.